§ 13F · FUND PROFILE
Lynx1 Capital Management LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $491.3T (13F)Positions · 14Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$35.1T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | STOK | STOKE THERAPEUTICS INC | 5.40M | $171.5T | 34.7% | ±0% |
| 2 | GHRS | GH RESEARCH PLC | 10.41M | $132.2T | 26.8% | +21% |
| 3 | CGEM | CULLINAN THERAPEUTICS INC | 8.96M | $92.8T | 18.8% | +55% |
| 4 | DNLI | DENALI THERAPEUTICS INC | 1.74M | $28.7T | 5.8% | +564% |
| 5 | CCCC | C4 THERAPEUTICS INC | 7.10M | $13.6T | 2.7% | ±0% |
| 6 | XNCR | XENCOR INC | 706K | $10.8T | 2.2% | NEW |
| 7 | IMTX | IMMATICS N.V | 922K | $9.7T | 2.0% | NEW |
| 8 | TCRX | TSCAN THERAPEUTICS INC | 8.02M | $8.0T | 1.6% | +2% |
| 9 | PASG | PASSAGE BIO INC | 624K | $7.4T | 1.5% | ±0% |
| 10 | KRRO | KORRO BIO INC | 678K | $5.4T | 1.1% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE LYNX1 SIGNAL
AC read
Lynx1 Capital Management LP is a Other fund managing $491299.8 trillion in assets. The fund runs a focused portfolio of just 14 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed